Upstream therapies after pulmonary vein ablation: five negative studies--what's next?

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

(2010) Kristian Wachtell et al.   BLOOD PRESSURE

The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females

(2010) D. Patel et al.   EUROPACE

Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation

(2010) M. H. Tayebjee et al.   EUROPACE

Combination of Uric Acid and NT-ProBNP: A More Useful Prognostic Marker for Short-Term Clinical Outcomes in Patients with Acute Heart Failure

(2010) Hyoung-Seob Park et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Valsartan for Prevention of Recurrent Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Current concepts in the pathogenesis of atrial fibrillation

(2008) Antonios Kourliouros et al.   AMERICAN HEART JOURNAL

Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms

(2008) A. Goette et al.   EUROPACE

Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation

(2008) K. P. Letsas et al.   EUROPACE